SEBI Reg. Investment Advisor

Download App
Help Center Pricing
Money Works 4 Me Logo MoneyWorks4Me
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

INVESTMENT INSIGHTS

Check Before You Invest : Global Longlife Hospital and Research Ltd

BSE: 543520 NSE: ISIN: INE0J2K01014
  |   Sector:  Healthcare   |   Industry:  Hospital & Healthcare Services

Snapshot

Q.1 Which industry/sub-sector does Global Longlife Hospital and Research Ltd belong to?
Global Longlife Hospital and Research Ltd belongs to the Healthcare sector, operating specifically within the Hospital & Healthcare Services segment.
Q.2 Is Global Longlife Hospital and Research Ltd a good quality company?
Global Longlife Hospital and Research Ltd is a quality company, based on a 10 year financial track record.
Q.3 Is Global Longlife Hospital and Research Ltd undervalued or overvalued?
Global Longlife Hospital and Research Ltd appears Somewhat Undervalued, as its key valuation ratios are below with their past averages.
Q.4 Is Global Longlife Hospital and Research Ltd a good buy now?
Global Longlife Hospital and Research Ltd is not a good buy now, based on weak price trend analysis suggesting prices may fall. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of Global Longlife Hospital and Research Ltd?
Global Longlife Hospital and Research Ltd revenue growth is -95.7% for FY-2025 , which is below its 5 year CAGR of -55.6% , indicating slower growth.
Q.2 Gross Profit margin of Global Longlife Hospital and Research Ltd?
Global Longlife Hospital and Research Ltd Gross profit margin which is the profit after deduction of direct costs, is 100.7% for FY-2025 , which is above its 5 year median of 16.5% , indicating increasing margins.
Q.3 Operating Profit Margin of Global Longlife Hospital and Research Ltd?
Global Longlife Hospital and Research Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is -717.06% for FY-2025 , which is below its 5 year median of 16.62% indicating decreasing margins.
Q.4 Net Profit Margin of Global Longlife Hospital and Research Ltd?
Global Longlife Hospital and Research Ltd Net Profit Margin is 34.42% for FY-2025 , is above with its 5 year median of 7.78%, indicating increasing margins.
Current Level Historic Median
Gross Profit Margin 100.7 16.5
Operating Profit Margin -717.06 16.62
Net Profit Margin 34.42 7.78
Q.5 Return on Asset of Global Longlife Hospital and Research Ltd?
Global Longlife Hospital and Research Ltd Return on Asset is 0.62%, which is below its 5 year historical median of 3.47%, indicating deteriorated asset utilization efficiency.
Q.6 Return on Equity (ROE) of Global Longlife Hospital and Research Ltd?
Global Longlife Hospital and Research Ltd Return on equity is 0.82% for FY-2025 , which is below its historical median of 4.82%, indicating the business is making worse use of its shareholders capital.
Q.7 Return on capital employed (ROCE) of Global Longlife Hospital and Research Ltd?
Global Longlife Hospital and Research Ltd Return on capital employed is 1.28% for FY-2025 , which is below its estimated weighted average cost of capital(WACC) 14%, indicating value preservation.
Q.8 Cash conversion cycle of Global Longlife Hospital and Research Ltd?
Global Longlife Hospital and Research Ltd Cash conversion cycle is 722 days, above its historical median of 103 days, indicating deteriorated working capital management. However, you need to compare this with its peers in the industry.
Current Level Historic Median
Asset Turnover 0.02 0.45
ROE 0.82 4.82
ROCE 1.28 6.69
Cash Conversion Cycle 722 days 103 days
Q.9 Debt to Equity ratio of Global Longlife Hospital and Research Ltd?
Global Longlife Hospital and Research Ltd Debt-to-Equity ratio is 0.00 , which is lower with the industry average of 0.22 , indicating lower debt levels in the industry.
Q.10 Debt to cash flow from operations of Global Longlife Hospital and Research Ltd?
Global Longlife Hospital and Research Ltd Debt to cash flow from operations is 0 , which is at a healthy level.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Global Longlife Hospital and Research Ltd?
Promoters hold 22.88% of the Global Longlife Hospital and Research Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Global Longlife Hospital and Research Ltd vs industry peers?
Global Longlife Hospital and Research Ltd revenue CAGR is -55.58% , compared to the industry median CAGR of 1.49% , indicating slower growth and losing its market share.
Profit Metrics
Current Level Industry Median
Revenue 0.6 144
Gross Profit 0.6 8.2
Operating Profit -4.1 8.4
Net Profit 0.2 5
Operating Efficiency
Current Level Industry Median
Asset Turnover 0.02 0.73
ROE 0.82 13.88
ROCE 1.28 17.77
Cash Conversion Cycle (days) 722.2 2

Valuation & price assessment

Q.1 Stock return of Global Longlife Hospital and Research Ltd over the last decade?
Over the last 3 year(s), the stock has delivered a CAGR of -30.53% based on the current price.
Q.2 What return has the stock given over the last decade?
9Y 5Y 3Y 1Y
Share Price - - -30.5% -26.8%
Q.3 Valuation ratios of Global Longlife Hospital and Research Ltd vs historical?
The current P/E is higher that its historical median.
Q.4 How do the current valuation ratios measure up against the historic numbers and the current industry numbers?
Valuation Ratios Current Historic Median Industry Median
Price to Earnings 80.22 25.96 79.71
Price to Book 0.64 0.74 3.54
Price to Sales 27.61 2.02 4.37
EV to EBITDA -6.34 13.08 18.04

Check more companies

1. Aster DM Healthcare
2. Global Health
3. Krishna Inst.Medi
4. Dr. Lal Pathlabs
5. Dr. Agarwals Health
6. RainbowChildrenS Med
7. Vijaya Diagnostic
8. Metropolis Health.
9. Park Medi World
10. HealthcareGlobal
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×